Essex LLC Abb Vie Inc. Transaction History

Essex LLC

$482 Million
Q3 2024

A detailed history of Essex LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Essex LLC holds 2,585 shares of ABBV stock, worth $465,300. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,585

Previous 2,722 5.03%

Holding current value

$465,300

Previous $466,000 9.44%

% of portfolio

0.11%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$163.84 - $199.33 $22,446 - $27,308	-137 Reduced 5.03%	2,585 $510,000
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $309 - $361	2 Added 0.07%	2,722 $466,000
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $15,342 - $17,481	-96 Reduced 3.41%	2,720 $495,000
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $66,460 - $74,850	-483 Reduced 14.64%	2,816 $436,000
Q3 2023 Oct 16, 2023	BUY	$133.59 - $154.65 $5,210 - $6,031	39 Added 1.2%	3,299 $491,000
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $89,179 - $110,977	-673 Reduced 17.11%	3,260 $439,000
Q4 2022 Jan 30, 2023	BUY	$138.31 - $165.87 $13,001 - $15,591	94 Added 2.45%	3,933 $636,000
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $9,931 - $11,390	-74 Reduced 1.89%	3,839 $515,000
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $16,376 - $20,820	-119 Reduced 2.95%	3,913 $599,000
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $52,660 - $65,336	-399 Reduced 9.0%	4,032 $654,000
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $2,041 - $2,582	-19 Reduced 0.43%	4,431 $600,000
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $473,480 - $537,471	4,450 New	4,450 $480,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex LLC with notifications on news.

Account